After an intensive planning phase and a construction period lasting one year, the pharma analysis and pharma consulting division of WESSLING located in Münster has doubled in size. For more than 15 years now, the experts at WESSLING in Johann-Krane-Weg in Technologiepark Münster have been analysing pharmaceuticals from nearly every sector, ranging from cancer medications to headache tablets.
“Fortunately, we had the opportunity to double the space for increasing customer enquiries at our well-established location through a generous extension,“ says Dr Maik Siebelmann, manager of the pharma location of WESSLING. More modern laboratories with high-quality technology were built on more than a thousand square metres. Around 40 employees conduct microbiological and chemical-physical analysis, and develop and validate new methods. In Münster, experts cooperate extensively with the Budapest location of WESSLING to support their international customers. Customers include pharmaceutical producers and pharmaceutical companies, who also seek advice from WESSLING on legal requirements and the introduction and implementation of new quality processes. Pharmaceuticals must undergo numerous controls during the manufacturing process in order to ensure quality and prevent counterfeit goods.
Specialised analysis in demand
The company in Münster also meets the market requirements for the medicinal testing of cannabis flowers. Special requirements include GMP certification (“Good Manufacturing Practice”) and narcotics approval. Our pharmaceutical experts examine the batches for identity, content and purity.